Marino Festa is an Honorary Fellow in the Critical Care and Trauma Division of The George Institute. He is a senior staff specialist and co-lead for Kids Critical Care Research at The Children’s Hospital at Westmead (CHW) in Sydney.

He is a fellow of the College of Intensive Care Medicine and has completed a Doctor of Medicine (Research), Imperial College, London 2011. He represents CHW on the paediatric study group of the ANZICS Clinical Trial Group and is principal investigator for the SAFE EPIC global point prevalence study.

He has active research interests in the areas of paediatric fluid resuscitation, microvascular adaptation to shock, and human factors research in critically ill and simulated patients.

Prof. Mark Huffman, a Professorial Fellow at The George Institute for Global Health and Adjunct Professor at UNSW, is a globally recognized preventive cardiologist with over a decade of experience in cardiovascular dissemination and implementation research. He is a Professor of Medicine (Cardiology) and Co-Director of the Global Health Center at Washington University in St. Louis and Adjunct Professor of Preventive Medicine at Northwestern University.

He is a Fellow of the American Heart Association and the American College of Cardiology and was recognised as an Emerging Leader in Health and Medicine through the National Academy of Medicine. He is a standing member of the NIH Science of Implementation for Health and Health Care study section.

He co-created the World Heart Federation’s flagship Emerging Leaders program, which has trained >200 early-to-mid-career professionals from >50 countries in implementation research. Prof. Huffman has taught graduate-level courses, co-directed the NIH/Fogarty-funded global health fellows’ research training program, and mentored undergraduate, graduate, postgraduate, and early-stage investigator trainees in implementation research.

Marna van Zyl is Legal Director at The George Institute.

Dr Meena Thuraisingham is Founder and Principal at BoardQ and TalentInvest. She is also a Non-Executive Director of the Shared Value Project and Linden Art Gallery.

Meena has previously held executive roles at ANZ, including Global Head of Leadership and Talent and Head of Human Resources, Corporate & Institutional Bank. She has also held senior consultant roles with two global consulting firms.

Meena joined the Board in January 2018 and is a Member of the Risk Committee.

A/Professor Meg Jardine is a Honorary Professorial Fellow at The George Institute for Global Health.

Her research interests centre on preventing the progression and complications of kidney disease and diabetes. She has a particular interest in using innovative trial designs to better generate evidence to improve outcomes. Dr Jardine leads the RESOLVE and BEAT-Calci trials and was the Global Scientific Lead of the CREDENCE study and CI of the ACTIVE and FINESSE trials. Her advocacy for kidney disease is pursued through memberships of the Board of the Kidney Health Initiative (KHI), the Executive Committee of the international KDIGO guidelines group and the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) core committee. 

Meg Jardine is a practising physician and nephrologist at Concord Repatriation General Hospital

Dr Menglu Ouyang is a research fellow at The George Insititute for Global Health and Conjoint Lecturer at UNSW. Her research field is in stroke, including acute care, clinical management, health system and implementation science. She has extensive experience in secondary analysis in large international clinical trials and implementation research. Her research contributes to filling the knowledge gap in stroke clinical guidelines development, informs implementation strategies and supports promoting the care embedded in existing processes in low- and middle-income countries.

She is the leading investigator for the process evaluation alongside the large international trials funded by MRC and NHMRC, to explore the feasibility, acceptability and implementation of evidence-based care. She also chairs the monthly Process Evaluation/Health System Research Seminar at The George Institute. She is in the UNSW Cardiac, Vascular, Metabolic Medicine Early Career Researcher Committee and the editor board of Cerebrovascular Diseases and Frontiers Public Health.

Ameer has a back ground in sociology. Prior to joining George Institute he served as Field Manager in the Administrative Staff College of India and Public Health Foundation of India. He has more than ten years experience in planning and managing large scale population based public health research studies.

He has particular expertise in community mobilization, site assessments, field management, and participatory mapping. He is currently working on the SMART Health project.

Murari is currently working as a Statistical Programmer in the George Institute or Global Health. He is an engineering graduate with Masters in Clinical Research from Medical University of South Carolina, USA. Additionally, he holds a Diploma in Clinical Data Management and Global Base and Advanced SAS Certification. He has 6 years of experience in Clinical Research domain and has worked extensively in Clinical Data Management and Statistical Programming. He has worked in Preterm Birth Cohort, Comprehensive National Nutritional Survey, Breast cancer and Tuberculosis Vaccine trial.  His area of expertise includes database programming and Biostatistics.

Namrata Nath Kumar is a Clinical Research Associate for the Renal and Metabolic Division. She has worked in the division since 2013, and is passionate about clinical trials to help improve patients’ quality of life. Her work on the SHARP-ER study introduced her to clinical research operations, where she was involved in coordination of site finance, patient surveys and data linkage processes with MBS and PBS datasets. She currently manages sites across Australia and New Zealand for the PRESERVE study, a double-blinded randomised controlled trial in the Cardiology setting. Through this study Namrata has become familiar with HREC and Governance processes across both countries, in addition to investigational product accountability, central labs and safety processes. In 2016 Namrata commenced on the STARRT-AKI study, which has widened her knowledge base to include Intensive Care clinical research. Her monitoring role on this project takes on responsibilities in site feasibility, start-up, initiation, and data management. While learning and growing in the clinical research field, Namrata sees herself pursuing further studies in public health and managing research projects in the near future.